Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Mycophenolic acid (MPA) is a potent immunosuppressive agent primarily used in organ transplantation and treatment of autoimmune diseases. It is a natural product derived from the fungus Penicillium brevicompactum and was the first antibiotic to be isolated and crystallized. MPA functions by inhibiting inosine monophosphate dehydrogenase, a key enzyme in the de novo synthesis of purine nucleotides, thereby suppressing lymphocyte proliferation. The biosynthesis of MPA involves compartmentalized pathways within the fungal cells, highlighting its complex structural features, including a 6-alkyl-2,4-dihydroxybenzoate moiety. Recent studies have explored novel derivatives of MPA, aiming to enhance its cytotoxic and antimicrobial activities, which have shown promising results against various cell lines. The development of biosimilars for MPA is supported by the FDA's bioequivalence standards, offering cost-effective alternatives for immunosuppressive therapy.
仅用于科研。不用于诊断过程。未经明确授权不得转售。